Clinical Trial Update: Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer [NA]

View source ↗

Summary

This clinical trial investigating pre-treatment with HPPH photodynamic therapy before chemoradiation for non-operable obstructive esophageal cancer was withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• HPPH (HPPH)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Esophageal Neoplasm | NA | Status: WITHDRAWN